Breaking News
December 10, 2018 - Some Brain Tumors May Respond to Immunotherapy, New Study Suggests
December 10, 2018 - Banning junk food ads to combat childhood obesity
December 10, 2018 - Skin Autofluorescence Predicts T2DM, Heart Disease, Mortality
December 10, 2018 - Largest autism sequencing study to date yields 102 genes associated with ASD
December 10, 2018 - Statins associated with low risk of side effects
December 10, 2018 - Study explores how schools address adolescent self-harming practices
December 10, 2018 - Pregnancy in adolescence linked to increased risks of complications in young mothers
December 10, 2018 - Risk Analysis publishes special issue on communicating about Zika virus
December 10, 2018 - Botox May Help Prevent Post-Op A-Fib
December 10, 2018 - African-American mothers rate boys higher for ADHD
December 10, 2018 - Graphic warning labels cancel out cigarettes’ appeal to young people
December 10, 2018 - Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
December 10, 2018 - Individual neurons located within the brain have implications for psychiatric diseases
December 10, 2018 - Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
December 10, 2018 - HPV type 16 or 18 associated with cervical cancer risk in young women
December 10, 2018 - Cervical cancer risk is higher in women with positive HPV, but no cellular abnormalities
December 10, 2018 - Combo therapy not needed if low RA disease activity achieved
December 10, 2018 - Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
December 10, 2018 - UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
December 10, 2018 - Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
December 10, 2018 - Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
December 10, 2018 - Study clarifies ApoE4’s role in dementia
December 10, 2018 - Eating disorders now a top priority with Australian Government
December 10, 2018 - Neuronal activity in the brain allows prediction of risky or safe decisions
December 10, 2018 - FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
December 10, 2018 - Improving dementia care and treatment saves thousands of pounds in care homes
December 10, 2018 - Heroin-assisted treatment can offer benefits, reduce harms
December 10, 2018 - People covered by Michigan’s expanded Medicaid program report improvements in health, finds study
December 10, 2018 - Hazelnuts improve micronutrient levels in older adults
December 9, 2018 - History of Partner Violence Tied to Menopause Symptoms
December 9, 2018 - Clean Up Safely After a Disaster|Natural Disasters and Severe Weather
December 9, 2018 - Drug wholesalers drove fentanyl’s deadly rise, report concludes
December 9, 2018 - Deprescribing could help manage polypharmacy in older adults
December 9, 2018 - Retraction of article “Joy of cooking too much” from journal
December 9, 2018 - FDA Warns of Rare Stroke Risk With MS Drug Lemtrada (Alemtuzumab)
December 9, 2018 - Feds say heroin, fentanyl remain biggest drug threat to US
December 9, 2018 - Eliminating microglia can reverse some aspects of stress sensitization, study shows
December 9, 2018 - New genetic insight could help treat rare debilitating heart and lung condition
December 9, 2018 - MiRagen Therapeutics Announces Final Safety, Biodistribution and Clinical Efficacy Data From Phase 1 Cobomarsen Clinical Trial in Patients With Mycosis Fungoides
December 9, 2018 - Work with your doctor to weigh pros, cons of treatment options for hyperthyroidism
December 9, 2018 - CWRU researcher secures $14.6 million funding for genetic study into Alzheimer’s disease
December 9, 2018 - High intensity statin treatment and adherence could save more lives
December 9, 2018 - Surgery patients use only 1/4 of prescribed opioids, and prescription size matters
December 9, 2018 - AXT offers Phi Optics upgrade to QPI systems for inverted light microscopes
December 9, 2018 - New booklet could help improve conditions of young pupils with albinism
December 9, 2018 - Few Physicians Work in Practices That Use Telemedicine
December 9, 2018 - Older Adults and Oral Health
December 9, 2018 - Health utility values improve after septorhinoplasty
December 9, 2018 - New EU-funded project provides insight into how the brain develops
December 9, 2018 - Expanded use of tele-emergency services can help strengthen rural hospitals
December 9, 2018 - Infections in the Young May Be Tied to Risk for Mental Illness: Study
December 9, 2018 - Profile: Native Hawaiians and Pacific Islanders
December 9, 2018 - Snoring poses greater cardiac risk to women
December 9, 2018 - Researcher takes further steps in understanding how and why cute aggression occurs
December 9, 2018 - Researchers create new light-activated tools for controlling neurons
December 9, 2018 - Spinal cord injury disrupts the body’s internal clock, study shows
December 9, 2018 - Babies recognize nested structures similar to our grammar
December 9, 2018 - UT Austin researcher receives $2.5 million CZI grant for neurodegenerative disease research
December 9, 2018 - Sleep problems found to be prevalent and increasing among college students
December 9, 2018 - Study reveals why some children are susceptible to the effects of maltreatment
December 9, 2018 - Study investigates influence of different opioids on driving performance
December 9, 2018 - Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia
December 9, 2018 - Eliminating microglia prevents heightened immune sensitivity after stress
December 9, 2018 - Boys with social difficulties are at greatest risk of early substance use
December 9, 2018 - ‘Wrong’ connective tissue cells linked to worse prognosis in breast cancer patients
December 8, 2018 - Chronic, refractory schizophrenia patients benefit from targeted cognitive training
December 8, 2018 - Advertising in kids’ apps more prevalent than parents may realize
December 8, 2018 - New way to trace the transmission histories of rare genetic diseases
December 8, 2018 - ASH: A+CHP Bests CHOP for Peripheral T-Cell Lymphoma
December 8, 2018 - Results of pediatric genomic epilepsy tests often reclassified
December 8, 2018 - New way of controlling HIV latency to completely eradicate the virus
December 8, 2018 - Phasefocus to showcase the Livecyte 2 at ASCB
December 8, 2018 - KHN’s ‘What the Health?’ Is health spending the next big political issue?
December 8, 2018 - Mussels take in microplastic pollution fibers and flush most of them out again
December 8, 2018 - AHA: How to Stop Smoking … for Good
December 8, 2018 - Scientists overturn odds to make Parkinson’s discovery
December 8, 2018 - Health benefits of producing marula vinegar
December 8, 2018 - Failure of critical cellular energy sensor responsible for CKD progression, study finds
December 8, 2018 - Ethnicity can be reliable indicator of gut microbiota diversity
December 8, 2018 - Safe Sleep for Baby | NIH News in Health
Scientists develop water-soluble warped nanographene for bioimaging

Scientists develop water-soluble warped nanographene for bioimaging

image_pdfDownload PDFimage_print

A new water-soluble nanocarbon triggers cell death when exposed to light

An international team of scientists has developed a water-soluble “warped nanographene”, a flexible molecule that is biocompatible and shows promise for fluorescent cell imaging. The new nanographene molecule also induces cell death when exposed to blue laser light. Further investigation is required to determine how nanocarbons could be used for a range of biological applications, such as photodynamic therapy for cancer treatments.

A group of chemists and biologists at Nagoya University and Boston College, have succeeded in synthesizing a water-soluble warped nanographene molecule that is water soluble for the first time. This new molecule, recently described in the journal Angewandte Chemie International Edition, expands the biological applications for nanocarbons, including cancer cell imaging and possibly eradication.

Nanographenes, nano-sized carbon molecules, exhibit unique electronic, optical and mechanical properties, and have been recognized as promising materials for electronic and biomedical purposes. However, the flat structure of nanographenes leads to stacking and aggregation in solvents, making it difficult to dissolve in various solvents and thus causing complications for biological applications.

In 2013, Professor Kenichiro Itami, director of the JST-ERATO Itami Molecular Nanocarbon Project and the Institute of Transformative Bio-Molecules (ITbM) at Nagoya University and his co-workers synthesized a warped nanographene molecule with a saddle-shape structure. The unique organization of the molecule’s 26 graphene rings prevents aggregation, making it soluble in most common organic solvents. Moreover, it exhibits green fluorescence when irradiated with ultraviolet or blue light.

“We were really excited when we succeeded in synthesizing the warped nanographene molecule, and we were interested in making it available for biological applications, which we achieved by adding water-soluble functional groups to the molecule,” says Itami.

In the latest study, Itami’s group explains how they developed a straightforward route to make warped nanographenes water soluble. First, they replaced five hydrogen atoms with boron moieties, through an iridium-catalyzed C-H borylation reaction. The boron-substituted warped nanographene is then mixed with a compound, called an aryl halide, containing water-soluble chains. A palladium-catalyzed Suzuki-Miyaura coupling reaction leads to the water-soluble chains attaching to the edges of the nanographene molecule, making it soluble in water and other organic solvents. This method can also be used to install other functional groups to warped nanographene to easily tune its properties.

The team examined the fluorescent properties of water-soluble warped nanographene. They found that under ultraviolet light, the molecule fluoresced yellow when dissolved in water, and fluoresced green when mixed in the common organic solvent dichloromethane. The new nanographene showed high photostability, meaning that its properties do not change when exposed to light. Rather, the color of fluorescence changes according to the polarity of the solvents that they are dissolved in.

Next, Itami’s team collaborated with ITbM’s biologists to test if the new molecule could stain live cells for fluorescent cell imaging. They treated HeLa cells, a strain of cervical cancer cells widely used in research, with a water-soluble warped nanographene solution. Microscopic observations showed that the cells took up the molecule over a few hours and it accumulated in the lysosomes, which are organelles found in cells. Cell viability did not change significantly over time, demonstrating that water-soluble warped nanographene has low cytotoxicity and could be used as a fluorescent stain for HeLa cells.

However, the molecule can turn deadly under certain circumstances. When the treated HeLa cells were irradiated with a blue laser, they exhibited cell death after 30 minutes. Untreated HeLa cells did not.

“Although our new warped nanographene has low toxicity to HeLa cells, we were surprised to find that cell death was observed upon irradiating light to the cells stained with the new nanographene,” says Itami.

The specific mechanism of how this cell death occurs is not clear yet, but the group speculates that a toxic singlet oxygen molecule is generated during irradiation and is responsible for cell death. Several other compounds are known to cause photo-induced cell death, but there is still a need to discover molecules that can absorb longer wavelengths to be safely used to treat cancer cells in deep tissues. The researchers envisage that their method to functionalize and tune warped nanographenes could lead to biocompatible molecules that absorb different wavelengths of irradiation.

“We have succeeded in synthesizing a water-soluble warped nanographene showing fluorescence, good photostability and low cytotoxicity, which makes it promising for bioimaging,” says Itami. “This achievement is an excellent example showing the output of the extensive collaboration between chemistry and biology ongoing at our institute. We hope that our molecules can be developed further for a wide range of biological applications through further interdisciplinary collaborations.”

The outcome of this study not only demonstrates the power of nanocarbons for biological applications, but also shows the rewarding synergy between synthetic chemistry and biology.

Source:

http://www.itbm.nagoya-u.ac.jp/en/research/2018/02/WSWNG.php

Tagged with:

About author

Related Articles